CURIA GLOBAL INC
ALBANY, NY, 12203
Prime contracting experience
49 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | CMC DEVELOPMENT OF (R)-VK4-116 DIHYDROCHLORIDE SALT | HHSN271201700005IUSAspending | $1,795,195 | Sep 24, 2026 | Sep 21, 2020 – Mar 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN) | HHSN271201800001IUSAspending | $3,167,871 | Sep 18, 2026 | Jun 1, 2020 – Jul 1, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137. | HHSN271201800001IUSAspending | $692,173 | Sep 18, 2026 | Sep 21, 2026 – Mar 20, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137. | HHSN271201800001IUSAspending | $669,175 | Sep 18, 2026 | Sep 21, 2026 – Mar 20, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | EXPLORATORY CHEMISTRY AND HIT-TO-LEAD CHEMISTRY OPTION. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2029. DAP-NCAP-00000137 | HHSN271201800001IUSAspending | $2,138,209 | Sep 18, 2026 | Sep 21, 2026 – Mar 20, 2029 |
| Prime | Department of Health and Human Services National Institutes of Health | ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203 | HHSN271201500005IUSAspending | $1,771,111 | Sep 14, 2026 | Sep 10, 2019 – Sep 12, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16) | HHSN271201500005IUSAspending | $273,065 | Sep 11, 2026 | Jan 15, 2015 – Jan 14, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | KATRITCH- UNIVERSITY OF SOUTHERN CALIFORNIA DMFP FOR BPN-35269 - CURIA GLOBAL, INC. | HHSN271201500005IUSAspending | $2,451,019 | Aug 5, 2026 | Sep 13, 2023 – Sep 12, 2029 |
| Prime | Department of Health and Human Services National Institutes of Health | NONCLINICAL SERVICES - SCALE-UP SYNTHESIS OF APX2039, A NOVEL GWT1 ENZYME INHIBITOR IN FUNGI | 75N93018D00008USAspending | $620,125 | Jul 16, 2026 | Aug 27, 2020 – Sep 30, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | NON-GMP SYNTHESIS OF COMPOUNDS. POP: 9/19/24-9/18/25. | — | $884,003 | Jun 26, 2026 | Sep 19, 2024 – Sep 18, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF DMFP TASK ORDER NO. 5 BUCKPITT BPN 19186 | HHSN271201500005IUSAspending | $1,191,883 | Sep 15, 2025 | Feb 5, 2016 – Jun 29, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | NIH BLUEPRINT NEUROTHERAPEUTICS NETWORK (BPN) MEDICINAL CHEMISTRY SUPPORT PROGRAM (MCSP) | HHSN271201800001IUSAspending | $251,981 | Sep 15, 2025 | Feb 24, 2020 – Sep 1, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | MCSP TORFP NO. NIH-NINDS-20-04: CHILDERS - BASE EC [SUBSTANCE USE DISORDER (COCAINE)] | HHSN271201800001IUSAspending | $631,254 | Aug 29, 2025 | Jun 1, 2020 – Sep 30, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | FLORIO BPN PROJECT BPN-36938 | HHSN271201500005IUSAspending | $2,502,592 | Aug 18, 2025 | Sep 17, 2024 – Sep 16, 2030 |
| Prime | Department of Health and Human Services National Institutes of Health | CHEMISTRY AND MANUFACTURING SERVICES - TASK C10 CHEMICAL SYNTHESIS AND PROCESS OPTIMIZATION OF STF-1759 | 75N93018D00008USAspending | $411,405 | Jul 10, 2025 | Jul 31, 2020 – Sep 30, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS | HHSN271201500005IUSAspending | $1,135,800 | Jun 2, 2025 | Jul 6, 2022 – Jun 2, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | MCSP TORFP NO. NIH-NINDS-21-02: TRUSHINA (MEDCHEM) - BASE EXPLORATORY CHEMISTRY (ALZHEIMER'S DISEASE) | HHSN271201800001IUSAspending | $607,397 | Jun 2, 2025 | Feb 4, 2021 – Jun 2, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | ALBANY MOLECULAR RESEARCH, INC(AMRI)[19-002417]MCSP TASK ORDER XU PROJECT - EXPLORATORY CHEMISTRY POP: TBD | HHSN271201800001IUSAspending | $555,782 | Apr 28, 2025 | Nov 30, 2018 – Apr 28, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | MCNAMARA EXPLORATORY CHEMISTRY | HHSN271201800001IUSAspending | $2,869,424 | Apr 3, 2025 | May 1, 2019 – Nov 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | MULCAHY EXPLORATORY CHEMISTRY | HHSN271201800001IUSAspending | $1,804,475 | Apr 2, 2025 | May 2, 2019 – Nov 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF TASK ORDER NO. 2 - "VAN LEYEN MCSP-EC" | HHSN271201800001IUSAspending | $3,403,139 | Feb 26, 2025 | May 4, 2018 – Oct 31, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL | HHSN271201700005IUSAspending | $907,792 | Dec 20, 2024 | Sep 30, 2023 – Apr 30, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO) | HHSN271201800001IUSAspending | $922,304 | Dec 12, 2024 | Dec 9, 2024 – Jun 8, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | PRODUCTION OF NON-GMP BATCHES OF PAYNANTHEINE, SPECIOGYNINE, AND SPECIOCILIATINE SALTS | HHSN271201700005IUSAspending | $1,174,494 | Nov 26, 2024 | Sep 16, 2020 – Apr 30, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES. | 75N93018D00008USAspending | $1,905,868 | Nov 13, 2024 | Jul 19, 2024 – Jan 18, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I | HHSN271201800001IUSAspending | $1,796,372 | Oct 10, 2024 | Sep 27, 2022 – Apr 14, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | ALBANY MOLECULAR RESEARCH INC - ROSENZWEIG | HHSN271201500005IUSAspending | $1,022,104 | Sep 27, 2024 | Sep 16, 2019 – Sep 29, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP) | — | $27,277,165 | Sep 27, 2024 | Aug 17, 2011 – Apr 15, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | SPIGELMAN (UCLA) - MCSP- EXPLORATORY CHEMISTRY (EC) | HHSN271201800001IUSAspending | $1,981,927 | Sep 6, 2024 | Aug 18, 2023 – Mar 4, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | MANUFACTURE OF 5.5-KG CGMP MITRAGYNINE | HHSN271201700005IUSAspending | $2,791,010 | Aug 2, 2024 | Aug 22, 2019 – May 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | MEDICINAL CHEMISTRY SERVICES TO SUPPORT PROJECT "ALDRICH (UNIV. OF FLORIDA) - EXPLORATORY CHEMISTRY-ADMET ONLY - MCSP" | HHSN271201800001IUSAspending | $404,158 | Jun 24, 2024 | May 12, 2023 – Dec 14, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | TO AWARD TASK C02 | 75N93018D00008USAspending | $542,766 | Jun 6, 2024 | Mar 22, 2019 – Mar 21, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | TO AWARD TASK C03 | 75N93018D00008USAspending | $860,163 | Jun 6, 2024 | Apr 12, 2019 – Apr 11, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | TO C-06: PREPARATION OF 400 GRAMS OF NON-GMP ANTIBIOTIC CANDIDATE FG-960-2 | 75N93018D00008USAspending | $610,341 | Jun 6, 2024 | Aug 20, 2019 – May 19, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | MARTIN (NUVONURO)-HIT TO LEAD CHEMISTRY-ADMET ONLY- MCSP-HEAL | HHSN271201800001IUSAspending | $256,491 | May 29, 2024 | Aug 1, 2023 – Feb 1, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC) | HHSN271201800001IUSAspending | $3,360,769 | May 29, 2024 | May 6, 2022 – Nov 13, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | SCALE UP FERMENTATION AND ISOLATION OF MEDINAMYCIN | 75N93018D00008USAspending | $554,127 | May 14, 2024 | Jan 3, 2022 – Sep 30, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | AL-ALI (UNIVERSITY OF MIAMI, SCHOOL OF MEDICINE) - MCSP - EXPLORATORY CHEMISTRY (EC) | HHSN271201800001IUSAspending | $3,173,499 | Mar 26, 2024 | Feb 1, 2022 – Feb 1, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I | HHSN271201800001IUSAspending | $1,471,823 | Dec 28, 2023 | Jul 27, 2022 – Sep 1, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | MANUFACTURE OF MBX-400 | 75N93018D00008USAspending | $1,056,500 | Sep 27, 2023 | Sep 1, 2022 – Oct 31, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | TSUKAMOTO (JOHNS HOPKINS UNIVERSITY) MCSP - LEAD OPTIMIZATION CHEMISTRY | HHSN271201800001IUSAspending | $1,474,682 | Sep 8, 2023 | Sep 9, 2023 – Mar 8, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | NON-GMP SYNTHESIS OF COMPOUNDS. CURIA GLOBAL, INC. JULY 25, 2023 - JULY 24, 2024. | — | $288,375 | Jul 25, 2023 | Jul 25, 2023 – Jul 24, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE) | HHSN271201800001IUSAspending | $3,420,025 | Jun 30, 2023 | Jan 26, 2021 – Dec 1, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | GANESH (EMORY UNIVERSITY) - MCSP - HIT TO LEAD CHEMISTRY | HHSN271201800001IUSAspending | $2,873,043 | Jun 30, 2023 | May 9, 2022 – Dec 1, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF TASK ORDER NO. 3 MILLER LO - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT | HHSN271201800001IUSAspending | $1,297,588 | Jun 27, 2023 | Aug 1, 2018 – Nov 30, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF TASK ORDER NO. 4 - ROSENZWEIG-LIPSON - MSCP - LO | HHSN271201800001IUSAspending | $1,376,050 | Jun 27, 2023 | Aug 15, 2018 – Nov 30, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | MCSP TORFP NO. NIH-NINDS-20-02: MOURADIAN/DISNEY - BASE EC (PARKINSON'S) | HHSN271201800001IUSAspending | $1,392,674 | Jan 30, 2023 | Jun 1, 2020 – Aug 31, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | NON-CLINICAL SERVICES IDIQ | 75N93018D00008USAspending | $443,000 | Sep 14, 2022 | Sep 14, 2022 – Dec 15, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF DMFP - TASK ORDER NO. 2 PETRUKHIN BPN-14967 | HHSN271201500005IUSAspending | $1,325,649 | Jun 29, 2022 | Apr 1, 2015 – Jun 30, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
11 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF-
2586
TASK 19: NON-GMP BATCH
SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL
SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY
" 63458883-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $207,900 | Jun 29, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF-
2586
TASK 19: NON-GMP BATCH
SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL
SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY
" 63458883-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $13,300 | May 14, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF-
2586
TASK 19: NON-GMP BATCH
SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL
SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY
" 63458883-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $844,600 | Jul 15, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF-
2586
TASK 19: NON-GMP BATCH
SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL
SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY
" 63458883-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $56,600 | Jun 24, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF-
2586
TASK 19: NON-GMP BATCH
SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL
SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY
" 63458883-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $337,600 | May 14, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | "PERFORM ADDITIONAL PROCESS DEVELOPMENT ACTIVITIES TO ESTABLISH A SUITABLE PROCESS PRIOR TO
THE 1 KG NON-GMP STF-4326 CAMPAIGN. THIS INCLUDES ONE-MONTH DEVELOPMENT WORK FOR
THE SELECTED SALT FORM TO GET THE PROCESS READY FOR THE 1 KG SCALE;
O PREPARE THE REQUESTED ~15 G OF THE SELECTED SALT FOR IN VIVO EVALUATION; AND
O GENERATE A FINAL DEVELOPMENT REPORT." 63459539-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $34,500 | Dec 19, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | "PERFORM ADDITIONAL PROCESS DEVELOPMENT ACTIVITIES TO ESTABLISH A SUITABLE PROCESS PRIOR TO
THE 1 KG NON-GMP STF-4326 CAMPAIGN. THIS INCLUDES ONE-MONTH DEVELOPMENT WORK FOR
THE SELECTED SALT FORM TO GET THE PROCESS READY FOR THE 1 KG SCALE;
O PREPARE THE REQUESTED ~15 G OF THE SELECTED SALT FOR IN VIVO EVALUATION; AND
O GENERATE A FINAL DEVELOPMENT REPORT." 63459539-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $116,000 | May 31, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF-
2586
TASK 19: NON-GMP BATCH
SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL
SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY
" 63458883-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $206,500 | May 31, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK AND TECHNICAL JUSTIFICATION
PREPARATION OF 5 GRAMS OF STF-4326 FREE ACID, 5 GRAMS OF STF-4326 PHOSPHORIC ACID SALT, AND 5 GRAMS OF
STF-4326 SODIUM SALT
TASK 2: CHEMISTRY PROCESS/PRE-FORMULATION
SUBTASK 2A: CHEMISTRY PROCESS SCALE-UP AND PROCESS OPTIMIZATION" 63065154-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $32,500 | May 29, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | "CURIA
DESCRIPTION OF WORK
CONDUCT OF A PRELIMINARY SALT SCREEN AND EVALUATION OF PHYSICAL PROPERTIES OF SELECTED CANDIDATE.
DETAIL DESCRIPTION OF WORK INVOLVED IS FOUND IN THE CURIA PROPOSAL, SEE SECTIONS 1.1 AND 1.2.
BASE PERIOD
TASK 2: CHEMISTRY PROCESS/PRE-FORMULATION
SUBTASK 2C: POLYMORPH, SALT SCREEN AND API CHARACTERIZATION DRUG SUBSTANCE PREFORMULATION ACTIVITIES:
STABILITY, SOLUBILITY AND CRYSTALLIZATION STUDIES" 63414670-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $182,583 | May 15, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | CURIA RECENTLY MANUFACTURED NON-GMP STF-2586 AND IS FAMILIAR WITH THE SYNTHESIS PROCESS AND ANALYTICAL METHODS FOR STF-2586. CURIA€„¢S QUOTE IS THE BEST COMBINATION OF EXISTING KNOWLEDGE OF THE STF-2586 PROGRAM (AND HENCE THE STF-4326 PROGRAM AS STF-2586 IS A STARTING MATERIAL OF STF-4326), PRICE, FLEXIBILITY AND APPARENT TECHNICAL COMPETENCY AND QUALITY AND COVERED ALL OUR REQUIREMENTS. OTHER VENDORS WHO WERE VETTED FOR STF-2586 PRODRUG ARE LOCATED IN UK OR IN CHINA. CURIA IS LOCATED IN NY, USA, AND HENCE MAKING THE COMMUNICATIONS EASIER WITH THE STANFORD TEAM WHO IS LOCATED IN CA, USA. THEREFORE, WE CHOSE CURIA FOR PROCESS DEVELOPMENT OF STF-4326. CURIA PROVIDES EXTENSIVE KNOWLEDGE IN THE FIELD OF PROCESS CHEMISTRY AND MANUFACTURING. STANFORD LAB LACKS EXPERTISE IN TECHNICAL PROCESS CHEMISTRY WORK AND LARGER SCALE MANUFACTURING. FOR THESE ESSENTIAL ACTIVITIES WE REQUIRE A VENDOR THAT CAN PROVIDE US THIS EXPERTISE AND ENABLE US TO PROCEED WITH DRUG FORMULATIONS SUITABLE FOR NONCLINICAL STUDIES. CURIA IS A LEADING COMPANY WITH OVER 20+ YEARS OF EXPERIENCE WORKING WITH TOP PHARMACEUTICAL COMPANIES TO PROVIDE THE SERVICES WE REQUIRE IN ORDER TO SUCCESSFULLY ACHIEVE OUR PROGRAM GOALS. THEY ARE ABLE TO START THE WORK IMMEDIATELY, WHEREAS OTHER COMPANIES ARE NOT ABLE TO DO INITIATE THE WORK FOR SOMETIMES. 63065154-184638 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. View parent award on USAspending | — | $131,100 | Mar 10, 2023 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.